Validation of an Individualized Measure of Quality of Life, Patient Generated Index, for Use with People with Parkinson's Disease

Ayse Kuspinar; Kedar K V Mate; Anne-Louise Lafontaine; Nancy Mayo

doi:10.1155/2020/6916135

Validation of an Individualized Measure of Quality of Life, Patient Generated Index, for Use with People with Parkinson's Disease

Neurol Res Int. 2020 Mar 30:2020:6916135. doi: 10.1155/2020/6916135. eCollection 2020.

Authors

Ayse Kuspinar¹, Kedar K V Mate², Anne-Louise Lafontaine^{3

4}, Nancy Mayo^{2

5}

Affiliations

¹ School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada.
² Center for Outcomes Research and Evaluation, McGill University Health Centre-Research Institute, Montreal, QC, Canada.
³ Neurology, McGill University Health Centre, Montreal, QC, Canada.
⁴ Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
⁵ School of Physical and Occupational Therapy, McGill University, Montreal, QC, Canada.

Abstract

Methods: Patients with PD completed the PGI and various standard patient-reported outcome (PRO) measures. The PGI and standard PRO measures were compared at the total score, domain, and item levels. Pearson's correlations and independent t-tests were used, as well as positive and negative predictive values.

Results: The sample (n = 76) had a mean age of 69 (standard deviation 9) and were predominantly men (59%). The PGI was moderately correlated (r = -0.35) with the standardized disease-specific QOL measure Parkinson's Disease Questionnaire (PDQ-8). Within one severity rating, agreement between the PGI and different standard outcome measures ranged from 85 to 100% for walking, 69 to 100% for fatigue, 38 to 75% for depression, and 20 to 80% for memory/concentration.

Conclusion: This study demonstrates that nominated areas of QOL on the PGI provide comparable results to standard PRO measures, and provides evidence in support of the validity of this individualized measure in PD.